Wendy Bernhard

576 total citations
26 papers, 418 citations indexed

About

Wendy Bernhard is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Wendy Bernhard has authored 26 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Wendy Bernhard's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and HER2/EGFR in Cancer Research (7 papers). Wendy Bernhard is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and HER2/EGFR in Cancer Research (7 papers). Wendy Bernhard collaborates with scholars based in Canada, Cuba and Egypt. Wendy Bernhard's co-authors include Kris Barreto, C. Ronald Geyer, Humphrey Fonge, Ivan Sadowski, Wayne Hill, Ayman El‐Sayed, V. Raja Solomon, Elahe Alizadeh, Pauline Johnson and Amy Saunders and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

Wendy Bernhard

23 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wendy Bernhard Canada	13	156	138	112	102	81	26	418
Louise Saul United Kingdom	9	45 0.3×	78 0.6×	58 0.5×	48 0.5×	24 0.3×	12	334
M. Edward United Kingdom	11	69 0.4×	171 1.2×	18 0.2×	109 1.1×	39 0.5×	23	495
Minna Zheng China	9	234 1.5×	90 0.7×	32 0.3×	83 0.8×	39 0.5×	21	415
Armelle Goubard France	13	32 0.2×	262 1.9×	75 0.7×	221 2.2×	74 0.9×	25	586
Meng Jin China	9	20 0.1×	55 0.4×	65 0.6×	56 0.5×	32 0.4×	27	272
Benjamin Müller Germany	12	35 0.2×	158 1.1×	12 0.1×	41 0.4×	86 1.1×	29	381
Ying Hua China	10	289 1.9×	262 1.9×	7 0.1×	106 1.0×	54 0.7×	12	490
Amélie Bouchard Canada	11	34 0.2×	262 1.9×	74 0.7×	249 2.4×	20 0.2×	13	613
M. Park Canada	6	19 0.1×	162 1.2×	26 0.2×	62 0.6×	45 0.6×	7	308
Winnie Ngo United States	9	18 0.1×	283 2.1×	56 0.5×	165 1.6×	72 0.9×	10	512

Countries citing papers authored by Wendy Bernhard

Since Specialization

Citations

This map shows the geographic impact of Wendy Bernhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Bernhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Bernhard more than expected).

Fields of papers citing papers by Wendy Bernhard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Bernhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Bernhard. The network helps show where Wendy Bernhard may publish in the future.

Co-authorship network of co-authors of Wendy Bernhard

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Bernhard. A scholar is included among the top collaborators of Wendy Bernhard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Bernhard. Wendy Bernhard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bernhard, Wendy, et al.. (2026). Antibody‐Targeted Artificial T Cell and Natural Killer Cell Derived Vesicles for Cancer Immunotherapy. Journal of Extracellular Vesicles. 15(2). e70231–e70231.

Allan, Nick, Jacob M. Hooker, Wendy Bernhard, et al.. (2025). Olfactory Drug Delivery in Rodents: Deposition and Pharmacokinetics. ACS Pharmacology & Translational Science. 8(7). 2167–2179.

Bernhard, Wendy, et al.. (2024). Antibody-targeted T cells and natural killer cells for cancer immunotherapy. Journal of Nanobiotechnology. 22(1). 640–640. 1 indexed citations

Bernhard, Wendy, et al.. (2022). Rapid Copper-free Click Conjugation to Lipid-Shelled Microbubbles for Ultrasound Molecular Imaging of Murine Bowel Inflammation. Bioconjugate Chemistry. 33(5). 848–857. 6 indexed citations

Alizadeh, Elahe, Khan Behlol Ayaz Ahmed, V. Raja Solomon, et al.. (2021). 89Zr-Labeled Domain II-Specific scFv-Fc ImmunoPET Probe for Imaging Epidermal Growth Factor Receptor In Vivo. Cancers. 13(3). 560–560. 9 indexed citations

Bernhard, Wendy, Kris Barreto, Ayman El‐Sayed, et al.. (2021). Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety. BMC Cancer. 21(1). 270–270. 12 indexed citations

Solomon, V. Raja, Elahe Alizadeh, Wendy Bernhard, et al.. (2020). Development and preclinical evaluation of cixutumumab drug conjugates in a model of insulin growth factor receptor I (IGF-1R) positive cancer. Scientific Reports. 10(1). 18549–18549. 10 indexed citations

Bernhard, Wendy, et al.. (2019). Near infrared imaging of epidermal growth factor receptor positive xenografts in mice with domain I/II specific antibody fragments. Theranostics. 9(4). 974–985. 10 indexed citations

Hartimath, Siddesh V., Elahe Alizadeh, V. Raja Solomon, et al.. (2019). Preclinical Evaluation of¹¹¹In-Labeled PEGylated Maytansine Nimotuzumab Drug Conjugates in EGFR-Positive Cancer Models. Journal of Nuclear Medicine. 60(8). 1103–1110. 28 indexed citations

10.

Wahid, Khan A., et al.. (2019). A Low-Cost and Portable Smart Instrumentation for Detecting Colorectal Cancer Cells. Applied Sciences. 9(17). 3510–3510. 8 indexed citations

11.

Solomon, V. Raja, Elahe Alizadeh, Wendy Bernhard, et al.. (2019). ¹¹¹In- and ²²⁵Ac-Labeled Cixutumumab for Imaging and α-Particle Radiotherapy of IGF-1R Positive Triple-Negative Breast Cancer. Molecular Pharmaceutics. 16(12). 4807–4816. 30 indexed citations

12.

El‐Sayed, Ayman, Wendy Bernhard, Kris Barreto, et al.. (2018). Evaluation of antibody fragment properties for near-infrared fluorescence imaging of HER3-positive cancer xenografts. Theranostics. 8(17). 4856–4869. 29 indexed citations

13.

Solomon, V. Raja, Carolina González, Elahe Alizadeh, et al.. (2018). 99mTc(CO)3+ labeled domain I/II-specific anti-EGFR (scFv)2 antibody fragment for imaging EGFR expression. European Journal of Medicinal Chemistry. 157. 437–446. 10 indexed citations

14.

Alam, Md. Kausar, Ayman El‐Sayed, Kris Barreto, et al.. (2018). Site-Specific Fluorescent Labeling of Antibodies and Diabodies Using SpyTag/SpyCatcher System for In Vivo Optical Imaging. Molecular Imaging and Biology. 21(1). 54–66. 26 indexed citations

15.

Solomon, V. Raja, Elahe Alizadeh, Wendy Bernhard, et al.. (2018). 89Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I. Oncotarget. 9(24). 17117–17132. 28 indexed citations

16.

Barreto, Kris, Wendy Bernhard, Nicolette S. Honson, et al.. (2017). Compounds producing an effective combinatorial regimen for disruption of HIV ‐1 latency. EMBO Molecular Medicine. 10(2). 160–174. 20 indexed citations

17.

Bernhard, Wendy, Ayman El‐Sayed, Kris Barreto, et al.. (2017). Near infrared fluorescence imaging of EGFR expressionin vivousing IRDye800CW-nimotuzumab. Oncotarget. 9(5). 6213–6227. 21 indexed citations

18.

Hashemi, Farhad B., et al.. (2016). HIV Provirus Stably Reproduces Parental Latent and Induced Transcription Phenotypes Regardless of the Chromosomal Integration Site. Journal of Virology. 90(11). 5302–5314. 18 indexed citations

19.

Bernhard, Wendy, Kris Barreto, Sheetal A. Raithatha, & Ivan Sadowski. (2013). An Upstream YY1 Binding Site on the HIV-1 LTR Contributes to Latent Infection. PLoS ONE. 8(10). e77052–e77052. 25 indexed citations

20.

Bernhard, Wendy, Kris Barreto, Amy Saunders, et al.. (2011). The Suv39H1 methyltransferase inhibitor chaetocin causes induction of integrated HIV-1 without producing a T cell response. FEBS Letters. 585(22). 3549–3554. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact